Cargando…
Comparative efficacy evaluation of disinfectants against severe acute respiratory syndrome coronavirus-2
BACKGROUND: Disinfection is one of the most effective ways to block the rapid transmission of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). Due to the prolonged coronavirus disease 2019 (COVID-19) pandemic, disinfectants have become crucial to prevent person-to-person transmission an...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author(s). Published by Elsevier Ltd on behalf of The Healthcare Infection Society.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9639569/ https://www.ncbi.nlm.nih.gov/pubmed/36183929 http://dx.doi.org/10.1016/j.jhin.2022.09.011 |
_version_ | 1784825668947673088 |
---|---|
author | Lee, G-H. Park, S-H. Song, B-M. Kim, D-M. Han, H-J. Park, J-Y. Jo, Y-W. Hwang, M-Y. Sim, K-T. Kang, S-M. Tark, D. |
author_facet | Lee, G-H. Park, S-H. Song, B-M. Kim, D-M. Han, H-J. Park, J-Y. Jo, Y-W. Hwang, M-Y. Sim, K-T. Kang, S-M. Tark, D. |
author_sort | Lee, G-H. |
collection | PubMed |
description | BACKGROUND: Disinfection is one of the most effective ways to block the rapid transmission of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). Due to the prolonged coronavirus disease 2019 (COVID-19) pandemic, disinfectants have become crucial to prevent person-to-person transmission and decontaminate hands, clothes, facilities and equipment. However, there is a lack of accurate information on the virucidal activity of commercial disinfectants. AIM: To evaluate the virucidal efficacy of 72 commercially available disinfectants constituting 16 types of ingredients against SARS-CoV-2. METHODS: SARS-CoV-2 was tested with various concentrations of disinfectants at indicated exposure time points as recommended by the manufacturers. The 50% tissue culture infectious dose assay was used to calculate virus titre, and trypan blue staining and CCK-8 were used to assess cell viability after 3–5 days of SARS-CoV-2 infection. FINDINGS: This study found that disinfectants based on 83% ethanol, 60% propanol/ethanol, 0.00108–0.0011% sodium dichloroisocyanurate and 0.497% potassium peroxymonosulfate inactivated SARS-CoV-2 effectively and safely. Although disinfectants based on 0.05–0.4% benzalkonium chloride (BAC), 0.02–0.07% quaternary ammonium compound (QAC; 1:1), 0.4% BAC/didecyldimethylammonium chloride (DDAC), 0.28% benzethonium chloride concentrate/2-propanol, 0.0205–0.14% DDAC/polyhexamethylene biguanide hydrochloride (PHMB) and 0.5% hydrogen peroxide inactivated SARS-CoV-2 effectively, they exhibited cytotoxicity. Conversely, disinfectants based on 0.04–4% QAC (2:3), 0.00625% BAC/DDAC/PHMB, and 0.0205–0.14% and 0.0173% peracetic acid showed approximately 50% virucidal efficacy with no cytotoxicity. Citric acid (0.4%) did not inactivate SARS-CoV-2. CONCLUSION: These results indicate that most commercially available disinfectants exert a disinfectant effect against SARS-CoV-2. However, re-evaluation of the effective concentration and exposure time of certain disinfectants is needed, especially citric acid and peracetic acid. |
format | Online Article Text |
id | pubmed-9639569 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | The Author(s). Published by Elsevier Ltd on behalf of The Healthcare Infection Society. |
record_format | MEDLINE/PubMed |
spelling | pubmed-96395692022-11-14 Comparative efficacy evaluation of disinfectants against severe acute respiratory syndrome coronavirus-2 Lee, G-H. Park, S-H. Song, B-M. Kim, D-M. Han, H-J. Park, J-Y. Jo, Y-W. Hwang, M-Y. Sim, K-T. Kang, S-M. Tark, D. J Hosp Infect Article BACKGROUND: Disinfection is one of the most effective ways to block the rapid transmission of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). Due to the prolonged coronavirus disease 2019 (COVID-19) pandemic, disinfectants have become crucial to prevent person-to-person transmission and decontaminate hands, clothes, facilities and equipment. However, there is a lack of accurate information on the virucidal activity of commercial disinfectants. AIM: To evaluate the virucidal efficacy of 72 commercially available disinfectants constituting 16 types of ingredients against SARS-CoV-2. METHODS: SARS-CoV-2 was tested with various concentrations of disinfectants at indicated exposure time points as recommended by the manufacturers. The 50% tissue culture infectious dose assay was used to calculate virus titre, and trypan blue staining and CCK-8 were used to assess cell viability after 3–5 days of SARS-CoV-2 infection. FINDINGS: This study found that disinfectants based on 83% ethanol, 60% propanol/ethanol, 0.00108–0.0011% sodium dichloroisocyanurate and 0.497% potassium peroxymonosulfate inactivated SARS-CoV-2 effectively and safely. Although disinfectants based on 0.05–0.4% benzalkonium chloride (BAC), 0.02–0.07% quaternary ammonium compound (QAC; 1:1), 0.4% BAC/didecyldimethylammonium chloride (DDAC), 0.28% benzethonium chloride concentrate/2-propanol, 0.0205–0.14% DDAC/polyhexamethylene biguanide hydrochloride (PHMB) and 0.5% hydrogen peroxide inactivated SARS-CoV-2 effectively, they exhibited cytotoxicity. Conversely, disinfectants based on 0.04–4% QAC (2:3), 0.00625% BAC/DDAC/PHMB, and 0.0205–0.14% and 0.0173% peracetic acid showed approximately 50% virucidal efficacy with no cytotoxicity. Citric acid (0.4%) did not inactivate SARS-CoV-2. CONCLUSION: These results indicate that most commercially available disinfectants exert a disinfectant effect against SARS-CoV-2. However, re-evaluation of the effective concentration and exposure time of certain disinfectants is needed, especially citric acid and peracetic acid. The Author(s). Published by Elsevier Ltd on behalf of The Healthcare Infection Society. 2023-01 2022-09-30 /pmc/articles/PMC9639569/ /pubmed/36183929 http://dx.doi.org/10.1016/j.jhin.2022.09.011 Text en © 2022 The Author(s) Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Lee, G-H. Park, S-H. Song, B-M. Kim, D-M. Han, H-J. Park, J-Y. Jo, Y-W. Hwang, M-Y. Sim, K-T. Kang, S-M. Tark, D. Comparative efficacy evaluation of disinfectants against severe acute respiratory syndrome coronavirus-2 |
title | Comparative efficacy evaluation of disinfectants against severe acute respiratory syndrome coronavirus-2 |
title_full | Comparative efficacy evaluation of disinfectants against severe acute respiratory syndrome coronavirus-2 |
title_fullStr | Comparative efficacy evaluation of disinfectants against severe acute respiratory syndrome coronavirus-2 |
title_full_unstemmed | Comparative efficacy evaluation of disinfectants against severe acute respiratory syndrome coronavirus-2 |
title_short | Comparative efficacy evaluation of disinfectants against severe acute respiratory syndrome coronavirus-2 |
title_sort | comparative efficacy evaluation of disinfectants against severe acute respiratory syndrome coronavirus-2 |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9639569/ https://www.ncbi.nlm.nih.gov/pubmed/36183929 http://dx.doi.org/10.1016/j.jhin.2022.09.011 |
work_keys_str_mv | AT leegh comparativeefficacyevaluationofdisinfectantsagainstsevereacuterespiratorysyndromecoronavirus2 AT parksh comparativeefficacyevaluationofdisinfectantsagainstsevereacuterespiratorysyndromecoronavirus2 AT songbm comparativeefficacyevaluationofdisinfectantsagainstsevereacuterespiratorysyndromecoronavirus2 AT kimdm comparativeefficacyevaluationofdisinfectantsagainstsevereacuterespiratorysyndromecoronavirus2 AT hanhj comparativeefficacyevaluationofdisinfectantsagainstsevereacuterespiratorysyndromecoronavirus2 AT parkjy comparativeefficacyevaluationofdisinfectantsagainstsevereacuterespiratorysyndromecoronavirus2 AT joyw comparativeefficacyevaluationofdisinfectantsagainstsevereacuterespiratorysyndromecoronavirus2 AT hwangmy comparativeefficacyevaluationofdisinfectantsagainstsevereacuterespiratorysyndromecoronavirus2 AT simkt comparativeefficacyevaluationofdisinfectantsagainstsevereacuterespiratorysyndromecoronavirus2 AT kangsm comparativeefficacyevaluationofdisinfectantsagainstsevereacuterespiratorysyndromecoronavirus2 AT tarkd comparativeefficacyevaluationofdisinfectantsagainstsevereacuterespiratorysyndromecoronavirus2 |